Eli Lilly Hits $1 Trillion Valuation
Update: 2025-11-24
Description
Eli Lilly, the first trillion-dollar pharma firm, surges due to weight-loss medication demand, outpacing Novo Nordisk. Despite a setback in August, investor confidence remains high, driven by a forty-seven percent stock jump in six months and positive financial results. The companys valuation is further boosted by the receding threat of tariffs on pharmaceutical imports.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
